The goal of International Conference and Exhibition on Cancer & Therapeutics (ICECT USA 2018) is to improve the care of Cancer patients by updating the oncology care providers about the new developments in the field. This ICECT USA 2018 conference also provides attendees with opportunities to interact and network with top experts in Cancer Research.
ICECT USA 2018 conference, we will learn about the most recent advances in the field of Cancer therapeutics from the basic science to clinical studies including the identification of novel targets; an improved understanding of the mechanisms of action of therapeutic interventions; as well as discussions about biomarkers of response to treatment and mechanisms of intrinsic and acquired resistance to cancer.
The main aims of this meeting are:
To contribute to the development of international recommendations and guidelines in the field.
The conference will be of interest to clinicians, oncologists, researchers, nurses, policy makers, and public and global health advocates working in cancer and it types. The meeting agenda is developed by multidisciplinary faculty led by prominent world experts, including oncology team, hemato-oncology team. The meeting is held on Jan 29-31, 2018, Las Vegas, USA. It includes international faculty and medical staff as well as scientists and Pharma who will share cutting edge developments in the field, aiming at the development and implementation of strategies for the prevention, early detection and management of oncology issues.
ICECT USA 2018 is going with very exciting in the context of oncology and in particular in the field of Cancer therapeutics. A deeper understanding of the molecular mechanisms involved in the interaction between the tumour and the immune system is revealing an attractive set of novel therapeutic approaches to treat cancer. With some pronounced recent successes in this field, this is fuelling aggressive investigation, leading to new questions and challenges.
There have been several new developments in the field of oncology. There is a need for educational sessions for healthcare providers involved in the management of solid tumors.
Educational Objectives of ICECT USA 2018 conference
As a result of attending the Conference, At the conclusion of this conference, participants & learners will be able to:
It is our pleasure to welcome you to the Cancer USA 2018 A Special Conference “Accelerating the Study and Research on Cancer & Therapeutics” to be held on 29-31 Jan 2018 in Las Vegas, USA
Hosted by the Helics Scientific Networks and Cancer Leadership 2018. Cancer USA 2018 is Special Conference & is built on the varies types Cancers and therapies. This is widely praised for the quality of its programme and inspirational contributions
The conference format is designed to bring together basic, translational and clinical researchers, as well as researchers working on the development of new targeted therapeutics. Leading experts will present the latest achievements of multidisciplinary research dealing with drug action and resistance and highlight challenges that require a concerted multidisciplinary effort. The programme will comprise Keynote Lectures, Plenary Symposia, and Scientific Symposia, Meet the Expert sessions, Oral and Poster presentations with ample time for discussion.
We trust you will share our excitement about the exceptional scientific programme of this meeting.
We cordially invite you to this unique conference and look forward to greeting you in Las Vegas.
|
Day – 1 |
Monday,January 29th, 2018 |
|
08:30 am – 09:00 am |
Registration Desk Opens |
|
09:00 am – 10:00 am |
Welcome Message |
|
10:00 am – 10:30 pm |
Networking Coffee Break & Exhibition Visit |
|
10:30 am – 12:30 pm |
Scientific Session 1 |
|
12:30 pm – 01:30 pm |
Networking Lunch & Exhibition Visit |
|
01:30 pm – 03:30 pm |
Poster Session 1 |
|
03:30 pm – 04:00 pm |
Networking Coffee Break & Exhibition Visit |
|
04:00 pm – 06:00 pm |
Scientific Session 2 |
|
|
Tuesday, January 30th, 2018 |
|
09:00 am – 10:30 am |
Scientific Session 3 |
|
10:30 am – 11:00 am |
Networking Coffee Break & Exhibition Visit |
|
11:00 am – 12:30 pm |
Poster Session 2 |
|
12:30 am – 01:30 pm |
Networking Lunch & Exhibition Visit |
|
01:30 pm – 03:00 pm |
E – poster presentation 1 |
|
03:00 pm – 03:30 pm |
Networking Coffee Break & Exhibition Visit |
|
03:30 pm – 06:00 pm |
Scientific Session 4 |
|
|
Wednesday, January 31st, 2018 |
|
09:00 am – 10:30 am |
Scientific Session 5 |
|
10:30 am – 11:00 am |
Networking Coffee Break & Exhibition Visit |
|
11:00 am – 12:30 pm |
Poster Session 3 |
|
12:30 am – 01:30 pm |
Networking Lunch & Exhibition Visit |
|
01:30 pm – 03:00 pm |
Scientific Session 6 |
|
03:00 pm – 03:30 pm |
Networking Coffee Break & Exhibition Visit |
|
03:30 pm – 06:00 pm |
Scientific Session 7 |
|
Award ceremony |
|
|
Conference Concludes |
|
|
Conference Details |
Dates |
|
1st Round Abstract Submission opens |
20 July 2017 |
|
1st Round Abstract Submission Deadline |
24 DEC 2017 |
|
Early Bird Registrations Opens |
15 June 2017 |
|
Early Bird Registration Deadline |
14 AUG 2017 |
|
Group Registration Deadline |
1 DEC 2017 |
|
Exhibitor Opportunity Ends |
5 DEC 2017 |
|
Sponsorship request Deadline |
10 DEC 2017 |
|
workshop request Submission |
Till 15 NOV 2017 |
|
Symposium Submission Deadline |
20 NOV 2017 |
|
Media Partner request Till |
25 NOV 2017 |
|
Advertising Opportunity Request |
30 NOV 2017 |
|
Volunteer Opportunity Ends |
20 DEC 2017 |
|
Press pass Opportunity Deadline |
25 DEC 2017 |
|
Presentation Dates 29 |
31 Jan 2018 |
Cell Proliferation/Cell cycle
Cell Death / Autophagy
Oncogenes and Tumour Suppressor Genes
Tumour Progression: Invasion and Metastasis
Tumour Microenvironment
Tumour Angiogenesis
Tumour Immunology AND Inflammation
Aging and Cancer
Senescence
Cancer Initiating Cells / Cancer Stem Cells
Tumour heterogeneity
Submit Your Abstract Suggest Your sessionMutagenesis, Carcinogen Metabolism
Promotion and Progression
DNA Damage and Repair
Viral Oncogenesis
Submit Your Abstract Suggest Your sessionGenomic Alterations in Cancer
Functional Genomics
Epigenetic mechanisms and RNA
Genetic instability
Deep sequencing
Immunology in the age of single cell genomics
Towards deciphering the functional genetic and neo-antigenic landscape in cancer
Tumor genomes shed light into mutational processes and cancer vulnerabilities
Inferring expressed genes by whole-genome sequencing of plasma DNA
Predicting relapse using circulating tumor DNA
Patient-derived primary cancer cells, integrative omics, and functional drug testing
Submit Your Abstract Suggest Your session
Preclinical Prevention Studies, Markers and Prevention
Clinical Prevention Studies
Vaccination Against Cancer
Submit Your Abstract Suggest Your sessionTumour Cell Sensitization to Radiotherapy
Radiation-activated Signaling Pathways
Cell Cycle and Apoptosis in Radiation Responses
Radiation Oncology; Preclinical and Clinical
Translational radiation research
Submit Your Abstract Suggest Your session
Risk Factors
Biomarkers
Risk Assessment
Susceptibility Genes
Genotype / Phenotype Correlations
Genetic Polymorphisms and Cancer Susceptibility
Epidemiology
Submit Your Abstract Suggest Your sessionDrug Discovery / Drug Design
Novel Targets, Delivery Systems
Mechanisms of Drug Action, Drug Profiling
Drug Resistance
Novel Approaches to Diagnosis of Cancer
New Therapies
Companion diagnostics
Personalized medicine
Submit Your Abstract Suggest Your session
Tumour Immunology
Immune Suppression and Escape
Tumor antigens and immune effectors
Immunotherapy and Cancer Vaccines
Cancer vaccines: preclinical and clinical studies
Submit Your Abstract Suggest Your session